Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Double Blind Evaluation of the Efficacy of a Single Dose of Synvisc-One® (6.0 cc) for the Treatment of Patellofemoral Chondromalacia

NCT01771952 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT01771952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01771952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Double Blind Evaluation of the Efficacy of a Single Dose of Synvisc-One® (6.0 cc) for the Treatment of Patellofemoral Chondromalacia
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2010
Completion date
October 31, 2016
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chondromalacia patella, patellofemoral pain syndrome